Adaptive Subsets Limit the Anti-tumoral NK-cell Activity in Hepatocellular Carcinoma
Perspectives for Novel Therapeutic Concepts in Hepatocellular Carcinoma Targeting the Stromal and Innate Immune Microenvironment
Intestinal B-cells License Metabolic T-cell Activation in NASH Microbiota/antigen-independently and Contribute to Fibrosis by IgA-FcR Signalling
Charakterisierung adaptiver NK-Zellen bei Patienten mit hepatozellulärem Karzinom